[1]
2025. The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review. Reumatismo. (Jul. 2025). DOI:https://doi.org/10.4081/reumatismo.2025.1835.